SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-14-041824
Filing Date
2014-07-08
Accepted
2014-07-07 21:47:42
Documents
15

Document Format Files

Seq Description Document Type Size
1 F-1/A v378842_f1a.htm F-1/A 2186550
2 EXHIBIT 3.2 v378842_ex3-2.htm EX-3.2 135564
3 EXHIBIT 23.1 v378842_ex23-1.htm EX-23.1 3049
4 GRAPHIC line.gif GRAPHIC 43
5 GRAPHIC logo_bioblast-lores.jpg GRAPHIC 15257
6 GRAPHIC logo_ey-motto.jpg GRAPHIC 6667
7 GRAPHIC spacer.gif GRAPHIC 43
8 GRAPHIC v371611_chrt-bar.jpg GRAPHIC 21047
9 GRAPHIC v371611_chrt-barcells.jpg GRAPHIC 33452
10 GRAPHIC v371611_chrt-barcells1.jpg GRAPHIC 39466
11 GRAPHIC v371611_tpg61.jpg GRAPHIC 82294
12 GRAPHIC v371611_tpg65.jpg GRAPHIC 74352
13 GRAPHIC v371611_tpg68.jpg GRAPHIC 160946
14 GRAPHIC v378842_chrt-shade.jpg GRAPHIC 29870
15 GRAPHIC v378842_chrt-tbl2.jpg GRAPHIC 165572
  Complete submission text file 0001144204-14-041824.txt   3194575
Mailing Address 35 AHAD HA'AM ST TEL AVIV L3 65202
Business Address 35 AHAD HA'AM ST TEL AVIV L3 65202 972 (0) 3 7326616
BIO BLAST PHARMA LTD. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-193824 | Film No.: 14964021
SIC: 2834 Pharmaceutical Preparations